Skip to main content
Figure 1 | BMC Musculoskeletal Disorders

Figure 1

From: Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

Figure 1

Scheme of the clinical trial visits in the three arms. V0 = Visit 0; S = Surgery; V1 = Visit 1 (24 hours after surgery); V2 = Visit 2 (72 hours after surgery); V3 = Visit 3 (the day of hospital discharge); V4 = Visit 4 (60 days after hospital discharge). A = Ferric carboximaltose + Erythropoietin; B = Ferric carboximaltose + Placebo; C = Placebo + Placebo

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us